Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016

Medical devices biocompatibility assessment on HCE: Evidences of delayed cytotoxicity of preserved compared to preservative free eye drops

(2019) Marisa Meloni et al.   REGULATORY TOXICOLOGY AND PHARMACOLOGY

Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections

(2018) Rupert R A Bourne et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness

(2018) Anton Hommer et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Referral for first glaucoma surgery in Europe, the ReF-GS study

(2018) Gábor Holló et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments

(2018) Pierre Dubrulle et al.   JOURNAL OF GLAUCOMA

Glaucoma

(2017) Jost B Jonas et al.   LANCET

French Medical-Administrative Database for Epidemiology and Safety in Ophthalmology (EPISAFE): The EPISAFE Collaboration Program in Cataract Surgery

(2017) Vincent Daien et al.   OPHTHALMIC RESEARCH

Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK)

(2016) Alberto Aguayo Bonniard et al.   Expert Opinion on Drug Metabolism & Toxicology

Apport clinique du latanoprost sans conservateur dans le traitement du glaucome à angle ouvert et de l’hypertension oculaire. Étude multicentrique randomisée contrôlée

(2016) P. Denis   JOURNAL FRANCAIS D OPHTALMOLOGIE

Ocular Surface Disease in Glaucoma

(2015) Norlina Ramli et al.   OPTOMETRY AND VISION SCIENCE

Global Prevalence of Glaucoma and Projections of Glaucoma Burden through 2040

(2014) Yih-Chung Tham et al.   OPHTHALMOLOGY

Benzalkonium chloride induces anterior chamber inflammation in previously untreated patients with ocular hypertension as measured by flare meter: a randomized clinical trial

(2012) Anna M. Stevens et al.   ACTA OPHTHALMOLOGICA

Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma

(2012) Jean-François Rouland et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Prevalence and Risk Factors for Ocular Surface Disease among Patients Treated over the Long Term for Glaucoma or Ocular Hypertension

(2012) Christophe Baudouin et al.   EUROPEAN JOURNAL OF OPHTHALMOLOGY

Ocular Surface Disease Exacerbated Glaucoma

(2012) Ruchika Batra et al.   JOURNAL OF GLAUCOMA

Ocular Surface Disease and Quality of Life in Patients With Glaucoma

(2011) Simon E. Skalicky et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Effects of glaucoma medications and preservatives on cultured human trabecular meshwork and non-pigmented ciliary epithelial cell lines

(2011) D. A. Ammar et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension

(2010) L. Jay Katz et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Preservatives in eyedrops: The good, the bad and the ugly

(2010) Christophe Baudouin et al.   PROGRESS IN RETINAL AND EYE RESEARCH

THE EFFECT OF BENZALKONIUM CHLORIDE ON THE ELECTROPOTENTIAL OF THE RABBIT CORNEA

(2009) KEITH GREEN et al.   ACTA OPHTHALMOLOGICA

Occludin gene expression as an early in vitro sign for mild eye irritation assessment

(2009) Marisa Meloni et al.   TOXICOLOGY IN VITRO